NAFLD NASH Diagnosis

NAFLD NASH Diagnosis

When excess fat is stored within the liver, it inhibits its ability to function. When a fatty liver isn’t the result of alcohol consumption, then the condition is known as nonalcoholic fatty liver disease (NAFLD). When the condition is severe enough to cause swelling and inflammation of the liver, it can lead to nonalcoholic steatohepatitis (NASH) which is associated with liver cancer and can progress to cirrhosis. There is no FDA-approved treatment for NASH, and NAFLD patients with advanced fibrosis are at an increased risk of succumbing to cardiovascular disease as well as cancer related mortality.

Our NASH diagnosis CME and CE as well as NAFLD CME and CE courses are designed to assist medical professionals in their efforts to diagnose and treat patients suffering from these increasingly prevalent conditions.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?